Related references
Note: Only part of the references are listed.Eplerenone in Patients With Systolic Heart Failure and Mild Symptoms Analysis of Repeat Hospitalizations
Jennifer K. Rogers et al.
CIRCULATION (2012)
ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012
John J. V. McMurray et al.
TURK KARDIYOLOJI DERNEGI ARSIVI-ARCHIVES OF THE TURKISH SOCIETY OF CARDIOLOGY (2012)
Eplerenone and new-onset diabetes in patients with mild heart failure: results from the Eplerenone in Mild Patients Hospitalization and Survival Study in Heart Failure (EMPHASIS-HF)
David Preiss et al.
EUROPEAN JOURNAL OF HEART FAILURE (2012)
ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012 The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC
John J. V. McMurray et al.
EUROPEAN HEART JOURNAL (2012)
Catalogue of EQ-5D Scores for the United Kingdom
Patrick W. Sullivan et al.
MEDICAL DECISION MAKING (2011)
Eplerenone in Patients with Systolic Heart Failure and Mild Symptoms.
Faiez Zannad et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Stopping Randomized Trials Early for Benefit and Estimation of Treatment Effects Systematic Review and Meta-regression Analysis
Dirk Bassler et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2010)
Factors determining utility measured with the EQ-5D in patients with atrial fibrillation
Jenny Berg et al.
QUALITY OF LIFE RESEARCH (2010)
Discrete Event Simulation: The Preferred Technique for Health Economic Evaluations?
Jaime J. Caro et al.
VALUE IN HEALTH (2010)
Utility Estimates for Decision-Analytic Modeling in Chronic Heart Failure-Health States Based on New York Heart Association Classes and Number of Rehospitalizations
Alexander Goehler et al.
VALUE IN HEALTH (2009)
Clinical epidemiology of heart failure
Arend Mosterd et al.
HEART (2007)
Resource utilization and costs in the Candesartan in Heart failure:: Assessment of Reduction in Mortality and morbidity (CHARM) programme
John J. V. McMurray et al.
EUROPEAN HEART JOURNAL (2006)
Carvedilol reduces the costs of medical care in severe heart failure: An economic analysis of the COPERNICUS study applied to the United Kingdom
S Stewart et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2005)
Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction
B Pitt et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
An economic analysis of specialist heart failure nurse management in the UK - Can we afford not to implement it?
S Stewart et al.
EUROPEAN HEART JOURNAL (2002)
The current cost of heart failure to the National Health Service in the UK
S Stewart et al.
EUROPEAN JOURNAL OF HEART FAILURE (2002)
More 'malignant' than cancer? Five-year survival following a first admission for heart failure
S Stewart et al.
EUROPEAN JOURNAL OF HEART FAILURE (2001)
Reduced costs with bisoprolol treatment for heart failure -: An economic analysis of the second Cardiac Insufficiency Bisoprolol Study (CIBIS-II)
P Bacquet et al.
EUROPEAN HEART JOURNAL (2001)
Survival of patients with a new diagnosis of heart failure: a population based study
MR Cowie et al.
HEART (2000)
Share Paper
